Abstract
dc:descriptionInvasive tumors, including gliomas, utilize proteinases to degrade extracellular matrix components and diffuse into the adjacent tissues or migrate towards distant ones. In addition, proteinase activity is required for the formation of new blood vessels within the tumor. Levels of the proteinase matrix metalloproteinase-2 (MMP-2) are highly increased in gliomas. In the present study, we examined the effect of the down-regulation of MMP-2 via adenovirus-mediated siRNA in gliomas. Here, we show that siRNA delivery significantly decreased levels of MMP-2 in the glioblastoma cell lines U-87 and U-251. U-87 and U-251 cells showed impaired invasion through matrigel as well as decreased migration from tumor spheroids. In addition, tumor-induced angiogenesis was decreased in in vitro experiments in cultured human endothelial cells (HMEC) and co-cultures of glioma cells with HMEC and VEGF excretion by tumor cells was reduced, whereas the addition of recombinant MMP-2 and VEGF significantly reversed the anti-angiogenic effect of the MMP-2 siRNA at the co-cultures. We also observed decreased angiogenesis in the in vivo dorsal skin-fold chamber model. After we applied irradiation at 10 Gray, MMP-2 was up-regulated by tumor cells and we observed an induction of tumor angiogenesis by approximately 10% at the co-cultures that the tumor cells were pre-irradiated. siRNA against MMP-2 efficiently inhibited the expression of MMP-2 in the irradiated tumor cells and blocked angiogenesis after irradiation in vitro. Down-regulation of MMP-2 interfered with the activity of intracellular signaling molecules and reduced phosphorylated levels of pI3K, pAKT and p38, even in the irradiated glioma cells, where we observed enhanced activity of p38. Moreover, MMP-2 inhibition induced apoptotic cell death in vitro, and suppressed tumor growth of pre-established U-251 intracranial xenografts in nude mice, whereas pre-infected with the adenovirus carrying the MMP-2 siRNA, U-251 glioblastoma cells failed to develop intracranial tumors after 6 weeks. Thus, specific targeting of MMP-2 may provide a novel, efficient approach for the treatment of gliomas and may contribute to the improvement of the poor outcomes of patients with these brain tumors.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2009
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Καργιώτης, Οδυσσέας
- Kargiotis, Odysseas
Subjects
dc:subject × 20- Γλοιώματα
- Διεισδυτικότητα
- Αγγειογένεση
- Μεταλλοπρωτεϊνάση του διάμεσου υποστρώματος-2 (mmp-2)
- RNA αλληλεπίδραση (rnai)
- Αγγειακός ενδοθηλιακός αυξητικός παράγοντας (VEGF)
- Αθυμικά ποντίκια
- Ιονίζουσα ακτινοβολία
- Gliomas
- Invasion
- Angiogenesis
- Matrix Metalloproteinase-2 (Mmp-2)
- RNA Interference (Rnai)
- Vascular endothelial growth factor (VEGF)
- Athymic Mice
- Ionizing Irradiation
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/17709